Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Research & Development (2020 - 2025)

Maravai Lifesciences Holdings has reported Research & Development over the past 6 years, most recently at $3.8 million for Q4 2025.

  • Quarterly results put Research & Development at $3.8 million for Q4 2025, down 16.95% from a year ago — trailing twelve months through Dec 2025 was $17.4 million (down 9.46% YoY), and the annual figure for FY2025 was $17.4 million, down 9.46%.
  • Research & Development for Q4 2025 was $3.8 million at Maravai Lifesciences Holdings, down from $3.8 million in the prior quarter.
  • Over the last five years, Research & Development for MRVI hit a ceiling of $9.2 million in Q4 2021 and a floor of $1.9 million in Q2 2021.
  • Median Research & Development over the past 5 years was $4.5 million (2023), compared with a mean of $4.4 million.
  • Biggest five-year swings in Research & Development: surged 339.01% in 2021 and later crashed 45.44% in 2022.
  • Maravai Lifesciences Holdings' Research & Development stood at $9.2 million in 2021, then crashed by 45.44% to $5.0 million in 2022, then decreased by 8.32% to $4.6 million in 2023, then dropped by 0.72% to $4.6 million in 2024, then decreased by 16.95% to $3.8 million in 2025.
  • The last three reported values for Research & Development were $3.8 million (Q4 2025), $3.8 million (Q3 2025), and $4.9 million (Q2 2025) per Business Quant data.